Drug Eluting Stent Market By Polymer Type (Bio-absorbable, Durable), By Material Type (Stainless steel, Cobalt chromium), By End User (Ambulatory surgical centers, Clinics, Hospitals), By Application (Coronary artery disease, Peripheral artery disease), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
Drug Eluting Stent Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.
  • Market Overview:

    Drug eluting stent is a small mesh tube that is inserted into a diseased peripheral or coronary artery to prevent the blockage occurring in the artery. The stent releases a drug that blocks cell proliferation by opening the artery and improving blood circulation. The sudden rise in prevalence of cardiovascular diseases across the globe, is fueling the demand for drug eluting stents. According to WHO, 17.7 million people die every year because of cardiovascular diseases, i.e. % of all global deaths. Moreover, growing geriatric population and rising incidence of lifestyle disorders such as obesity and diabetes have led to the increase in cardiac problems in patients, which is further expected to elevate the growth of global drug eluting stent market. As per the data revealed by State of Obesity, in United States, 1 out of 6 children and 1 out of 3 adults are obese. In addition, technological advancements in bio-absorbable stents is contributing towards the growth of the market. However, increasing preference for drugs over stent implant surgeries is the major factor that is hampering the growth of drug eluting stent market. Furthermore, risk associated with drug eluting stent such as stent thrombosis, disturbance of regrowth of endothelial tissues, and long term use of medication is challenging the growth of drug eluting stent market.

    The report provides detailed qualitative and quantitative analysis of the drug eluting stent market. Market size and forecast in terms of value and volume has been provided for the period – (2017 – 2025), for the segments namely polymer type, material type, end user, and application in each of the major regions.

    Drug Eluting Stent Market Segmentation

    By Polymer Type

    • Bio-absorbable polymer
    • Durable polymer

    By Material Type

    • Stainless steel
    • Cobalt chromium
    • Others

    By End User

    • Ambulatory surgical centers
    • Clinics
    • Hospitals

    By Application

    • Coronary artery disease
    • Peripheral artery disease

    By Geography

    • North America

    • U.S.
    • Canada
    • Mexico

    • Europe

    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe

    • Asia-Pacific

    • China
    • Japan
    • India
    • Korea
    • Rest of APAC

    • South America
    • Brazil
    • Rest of South America

    • Rest of the World

    • Middle East
    • Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources
    CHAPTER 2. DRUG ELUTING STENT MARKET OVERVIEW
    2.1. DRUG ELUTING STENT MARKET INTRODUCTION
    2.2. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Drug Eluting Stent Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL DRUG ELUTING STENT MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Drug Eluting Stent Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL DRUG ELUTING STENT MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Drug Eluting Stent Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL DRUG ELUTING STENT MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Drug Eluting Stent Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    CHAPTER 3. GLOBAL DRUG ELUTING STENT MARKET BY POLYMER TYPE, 2017-2025
    3.1. BIO-ABSORBABLE POLYMER
    3.2. DURABLE POLYMER
    3.3. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY POLYMER TYPE, 2017-2025
    3.3.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Polymer Type, 2017-2025
    3.3.2. Bio-absorbable polymer Market Revenue and Growth Rate, 2017-2025
    3.3.3. Durable polymer Market Revenue and Growth Rate, 2017-2025
    3.4. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION BY POLYMER TYPE, 2017-2025
    3.4.1. Global Drug Eluting Stent Market Production (Volume) and Share (%) By Polymer Type, 2017-2025
    3.4.2. Bio-absorbable polymer Market Production and Growth Rate, 2017-2025
    3.4.3. Durable polymer Market Production and Growth Rate, 2017-2025
    Note: Similar information coverage has been provided for material type segment.
    CHAPTER 4. GLOBAL DRUG ELUTING STENT MARKET BY APPLICATION, 2017-2025
    4.1. CORONARY ARTERY DISEASE
    4.2. PERIPHERAL ARTERY DISEASE
    4.3. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY APPLICATION, 2017-2025
    4.3.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.3.2. Coronary artery disease Market Revenue and Growth Rate, 2017-2025
    4.3.3. Peripheral artery disease Market Revenue and Growth Rate, 2017-2025
    4.4. GLOBAL DRUG ELUTING STENT MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.4.1. Global Drug Eluting Stent Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.4.2. Coronary artery disease Market Consumption and Growth Rate, 2017-2025
    4.4.3. Peripheral artery disease Market Consumption and Growth Rate, 2017-2025
    Note: Similar information coverage has been provided for end user segment.
    CHAPTER 5. GLOBAL DRUG ELUTING STENT MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL DRUG ELUTING STENT MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Drug Eluting Stent Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
    CHAPTER 6. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL DRUG ELUTING STENT MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global Drug Eluting Stent Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Drug Eluting Stent Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025
    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART
    CHAPTER 8. GLOBAL DRUG ELUTING STENT MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL DRUG ELUTING STENT PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Drug Eluting Stent Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL DRUG ELUTING STENT REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Drug Eluting Stent Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. DRUG ELUTING STENT MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Drug Eluting Stent Market Share (%) of Top 3 Manufacturers
    8.3.2. Drug Eluting Stent Market Share (%) of Top 5 Manufacturers
    CHAPTER 9. GLOBAL DRUG ELUTING STENT MANUFACTURERS ANALYSIS
    9.1. ABBOTT LABORATORIES
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Drug Eluting Stent Product Details
    9.1.4. Abbott Laboratories Drug Eluting Stent Production, Revenue and Gross Margin
    9.2. MERIL LIFE SCIENCES PVT.
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Drug Eluting Stent Product Details
    9.2.4. Meril Life Sciences Pvt. Drug Eluting Stent Production, Revenue and Gross Margin
    9.3. BOSTON SCIENTIFIC CORPORATION
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Drug Eluting Stent Product Details
    9.3.4. Boston Scientific Corporation Drug Eluting Stent Production, Revenue and Gross Margin
    9.4. MEDTRONIC PLC.
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Drug Eluting Stent Product Details
    9.4.4. Medtronic plc. Drug Eluting Stent Production, Revenue and Gross Margin
    9.5. BIOSENSORS INTERNATIONAL GROUP, LTD.
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Drug Eluting Stent Product Details
    9.5.4. Biosensors International Group, Ltd. Drug Eluting Stent Production, Revenue and Gross Margin
    9.6. BIOTRONIK SE & CO. KG
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. Drug Eluting Stent Product Details
    9.6.4. BIOTRONIK SE & Co. KG Drug Eluting Stent Production, Revenue and Gross Margin
    9.7. B. BRAUN MELSUNGEN AG
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. Drug Eluting Stent Product Details
    9.7.4. B. Braun Melsungen AG Drug Eluting Stent Production, Revenue and Gross Margin
    9.8. MICROPORT SCIENTIFIC CORPORATION, LTD.
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. Drug Eluting Stent Product Details
    9.8.4. MicroPort Scientific Corporation, Ltd. Drug Eluting Stent Production, Revenue and Gross Margin
    9.9. TERUMO CORPORATION
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. Drug Eluting Stent Product Details
    9.9.4. TERUMO CORPORATION Drug Eluting Stent Production, Revenue and Gross Margin
    9.10. TRANSLUMINA GMBH
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. Drug Eluting Stent Product Details
    9.10.4. Translumina GmbH Drug Eluting Stent Production, Revenue and Gross Margin
    CHAPTER 10. DRUG ELUTING STENT MARKET VALUE CHAIN ANALYSIS
    10.1. DRUG ELUTING STENT INDUSTRIAL CHAIN ANALYSIS
    10.2. DRUG ELUTING STENT KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. CONSUMER ANALYSIS
    10.3.1. Consumer 1
    10.3.2. Consumer 2
    10.3.3. Consumer 3
    10.3.4. Consumer 4

    keyboard_arrow_up
  • • Abbott Laboratories
    • Meril Life Sciences Pvt.
    • Boston Scientific Corporation
    • Medtronic plc.
    • Biosensors International Group, Ltd.
    • BIOTRONIK SE & Co. KG
    • B. Braun Melsungen AG
    • MicroPort Scientific Corporation, Ltd.
    • TERUMO CORPORATION
    • Translumina GmbH

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

What was the market size of the Drug Eluting Stent Market in 2017 and the expected market size by 2025, along with the growth rate?
An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
Which are the largest revenue generating products, services or regions and their comparative growth rate?
Which technology is in trend and how would it evolve during the forecast period (2017 – 2025)?
Which are the leading companies in the Drug Eluting Stent Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS